REGISTERED CHARITY NUMBER: 1164374
Report of the Trustees and Unaudited Financial Statements for the Year Ended 31 December 2025 for Action Bladder Cancer UK
Action Bladder Cancer UK
Contents of the Financial Statements for the Year Ended 31 December 2025
| Page | |
|---|---|
| Report of the Trustees | 1 to 8 |
| Independent Examiner's Report | 9 |
| Statement of Financial Activities | 10 |
| Balance Sheet | 11 |
| Notes to the Financial Statements | 12 to 17 |
| Detailed Statement of Financial Activities | 18 |
Action Bladder Cancer UK
Report of the Trustees
for the Year Ended 31 December 2025
The trustees present their report with the financial statements of the charity for the year ended 31 December 2025. The trustees have adopted the provisions of the Statement of Recommended Practice (SORP) 'Accounting and Reporting by Charities' issued in 2019.
REFERENCE AND ADMINISTRATIVE DETAILS Registered Charity number
1164374
Principal address
6 Trull Farm Buildings Tetbury Gloucestershire GL8 8SQ
Trustees
Roger Kockelbergh (Chair) Jeremy Crew Paula Allchorne Allen Knight Professor Rik Bryan Dr Mark Page Dr Peter Harper (Vice Chair) Caroline Raw Jenny Akins Alexandra Colquhoun
Independent Examiner
Woodlands Grange Woodlands Road Bradley Stoke Bristol BS32 4JY
Administrators
The Trust Partnership 6 Trull Farm Buildings Tetbury Gloucestershire GL8 8SQ
Page 1
Action Bladder Cancer UK
for the Year Ended 31 December 2025
Report of the Trustees
STRUCTURE, GOVERNANCE AND MANAGEMENT
Governing document
Action Bladder Cancer UK was constituted as a Charitable Incorporated Organisation on 9[th ] July 2015 and became registered charity on 12 November 2015. The Charity is governed by its present constitution which was adopted on 9[th ] July 2015. The Charity had originally been established as Action on Bladder Cancer in 2009.
Recruitment and appointment of new trustees
Where there is a requirement for new trustees, these would be identified and appointed by the current Trustees and elected by the members of Action Bladder Cancer UK at a General Meeting. The chair of Trustees is responsible for the induction of any new Trustee which involves a briefing on a Trustee's responsibilities, the governing document and policies, administrative procedures, the history of the Charity and the philosophical approach of the Charity. All Trustees provide their services as trustees for free.
Key management personnel
The Trustees consider that they, and the Clerk to the Trustees, comprise the key governance of the Charity. The Chief Executive manages the Charity and is in charge of directing and controlling, running and operating the Charity on a day to day basis, including income generation, management and development of the Charity. The Trustees receive no remuneration. The Chief Executive also manages the ABC UK core staff team including patient support staff , project staff and freelance staff.
Risk management
The Trustees have a duty to identify and review the risks to which the Charity is exposed and to ensure appropriate controls are in place to provide reasonable assurance against fraud and error. The Trustees have identified a register of risks which they review annually.
The Trustees have reviewed the risk register, the risks identified and the processes to manage or mitigate any risk. The Trustees are satisfied that all potential major risks have been considered and a mitigation management process identified. As part of this process, some of the key agreed actions are:
-
regular strategic reviews and communication of core charitable messages
-
a skills audit of Trustees to mitigate loss of core skills
-
delegations
-
a clear process for back up and cyber security of data
-
Trustee training and clear guidance on governance responsibilities and regulatory requirements
In looking to the future, the Trustees will continue to monitor the risks associated with its investments and continue to be vigilant as to other risks that might be associated with a grant making charity.
Page 2
Action Bladder Cancer UK
Report of the Trustees for the Year Ended 31 December 2025
OBJECTIVES AND ACTIVITIES
Objectives and aims
The objects of the Charity as defined by the constitution are the relief of sickness and preservation of health in particular but not exclusively by:
-
educating the public about bladder cancer and raising awareness of its prevalence, diagnosis and treatment.
-
working with health professionals, patients and carers to improve care and treatment of those with bladder cancer.
-
promoting and supporting research into bladder cancer and disseminating the useful results for the public benefit.
Public benefit
The T public benefit when reviewing the C policy for the year and that they have complied with the duty in section 17(5) of the 2011 Charities Act.
The trustees are satisfied that all charitable activities during the year are for the benefit of the public and the benefits of each and every activity are clearly identifiable.
-
1 Patient Support providing information and support on bladder cancer, including information materials, events (both online and face to face), and direct patient support.
-
2 Continued development of website to provide comprehensive information about bladder cancer for patients and health professionals.
-
3 Providing a bladder cancer Patient Support team working nationally to support patients and health professionals and build beneficial networks.
-
4 Continued development of network of regional Patient Support Groups to act on a local level. Linking with regional cancer and health networks to improve patient support.
-
5 Raising public awareness through campaigns, information materials, media and events.
-
6 Improving health professional awareness and knowledge through ABC UK Education Programme, education events, materials, information dissemination, and targeted media.
-
7 Raising awareness with influencers including government and others.
-
8 through involvement in clinical trials, research panels and providing patient input to research projects.
-
9 Campaigns and policy initiatives.
-
10 Collaborating with other organisations, and individuals, with an interest in bladder cancer to ensure a coordinated approach to raising awareness of the issues surrounding bladder cancer and enabling change.
Charitable activities
The Trustees normally meet four times a year to agree funding priorities, charitable activities, strategy and policy.
The Trust Partnership handle the central administration for Action Bladder Cancer UK and also look after the financial affairs of the Charity on a day to day basis.
The Charity is supported by an active network of core staff, project staff and volunteers, who help deliver programmes and projects, set up support groups and provide patient viewpoint on all new projects and materials produced by the Charity. The Charity is also actively assisted in its work by the involvement of specialist clinicians, researchers and nurses.
Page 3
Action Bladder Cancer UK
Report of the Trustees
for the Year Ended 31 December 2025
ACHIEVEMENT AND PERFORMANCE
Action Bladder Cancer UK continues to have a major impact with significant achievements and successful development of new programmes and projects. We have expanded our programmes of work significantly in recent years, and will be continuing to build on this growth. Our core team continue to deliver our programmes with great commitment, supported by our volunteer networks, which continue to grow and have increased significantly in 2025. We have a planned strategy for continued growth in 2025 and onwards. ABC UK Trustees are a highly valued source of expertise and commitment and represent bladder cancer patients, clinicians, nursing and cancer research. We thank our Trustees for their continued commitment and work as members of the board in 2025, there are currently 10 Trustees on the board.
Trustees were pleased that ABC UK continues to develop our vital work in 2025, and also to build on our programmes, including new activity launched in 2025. We have continued to grow our Health Professional Education Programme by developing resources and an annual programme of events, both for primary care and specialist nurses. We continue to expand our core activity to support patients, raise awareness, and our grants funding programmes. The need for our work is greater than ever.
areas of activity are: improving awareness of the symptoms of bladder cancer and the issues relating to an under-researched and under-funded condition and the unmet needs of patients, improving patient support, improving outcomes for bladder cancers patients, providing learning programmes and resources on bladder cancer for health professionals, and funding and encouraging research into bladder cancer. A summary of key activity is below.
AWARENESS RAISING
We work to raise the profile of bladder cancer and the unmet needs of patients across the UK:
-
Working to raise awareness of the symptoms of bladder cancer;
-
Disseminate ABC UK materials widely both print and online;
-
Social media and online presence, awareness raising via print articles and broadcast media;
-
Events, seminars, conferences; Staff and Volunteer led awareness raising events;
-
Policy initiatives and stakeholder engagement.
PATIENT SUPPORT
Patient Information and Direct Patient Support
-
Bladder cancer information both online and in print;
-
Direct patient support by phone and online;
-
ABC UK Patient Support team and Patient Advisors;
-
Patient focus group which helps to guide our work;
-
Bladder cancer patient support groups;
-
Patient events online and face to face.
SUPPORTING AND EDUCATING HEALTH PROFESSIONALS
ABC UK works closely with health professionals. There is a lack of learning opportunities for health professionals regarding bladder cancer. ABC UK are working to improve this by:
-
Delivering a nurse education programme;
-
Working with nurses to set up and run support groups for bladder cancer patients;
-
Delivering a Primary Care Education Programme;
-
Developing new resources for health professionals;
-
Developing new patient materials; training days, events and conferences; articles and input for healthcare publications; information materials and advice.
Primary Care Education
Raising awareness amongst GPs to improve early diagnosis of bladder cancer is a core activity for ABC UK.
-
GP webinars on symptoms and diagnosis of bladder cancer.
-
Launching a successful online learning module for GPs in September 2024.
-
Developing new bladder cancer resources for Primary Care, newsletters and other communications.
-
Working with NHSE and regional networks to reach more GPs.
Nurse Education Programme
-
Building our Nurse Education Programme by developing an annual programme of learning events.
-
ABC UK Nurse Education Annual Education Day.
-
Other events and study days, webinars.
-
Health Professional networking, newsletter and other communications.
Page 4
Action Bladder Cancer UK
for the Year Ended 31 December 2025
Report of the Trustees
RESEARCH
The significant lack of research investment into bladder cancer has a direct impact on the development of new treatments, poor patient outcomes, and the patient experience. We work to improve research into bladder cancer by:
- Improving Outcomes for Patients Programme (IOPP).
-
grants for specialist nurses.
-
ABC UK Research Projects defined pieces of work commissioned or undertaken directly by ABC UK.
-
ABC UK Surveys including patient surveys and specialist nurses surveys.
-
Substantial Patient and Public Involvement support to major bladder cancer clinical trials
-
Patient input to many other academic and clinical research projects.
-
Action Bladder Cancer UK is a National Institute for Health Research (NIHR) non-commercial Partner.
ABC UK Improving Outcomes for Patients Programme - IOPP and ABC UK Nursing Awards
The 2024/2025 round of IOPP grants, which were awarded in late Spring 2025, again provided some excellent applications, and we were also pleased to award the third The high quality of these grant applications continues to impress, and also to demonstrate the importance of helping to advance much-needed research into bladder cancer.
The 2025/2026 grant rounds for both IOPP and the ABC UK Nursing Awards launched in November 2025 for grants to be awarded in May 2026.
PUTTING THE PATIENT PERSPECTIVE
We continue to support, provide patient input to, and publicise, clinical trials for bladder cancer treatments, and assist with patient recruitment and provide feedback and input into trial development. We also contribute to consultations and expert roundtables and provide patient briefing and viewpoint to many within the bladder cancer sector. We regularly attend conferences, seminars and study days for health professionals - such as urologists, cancer nursing specialists and urology nurses - and provide patient representatives for advisory boards and research panels and carry out our own research.
POLICY
We are regular contributors to NICE, SMC, PHE, NIHR consultations relating to bladder cancer. Priority areas of ABC UK policy activity in 2025 and on-going includes:
-
Policy work to lobby NICE for a long-overdue updating of the NICE Bladder Cancer Guideline we are pleased that NICE have now commenced the process for a (partial) update of the Guideline;
-
Lobbying for a bladder cancer National Audit;
-
Undertaking Parliamentary engagement to raise the profile of bladder cancer with MPs and members of the House of Lords; Member of Parliamentary cancer group;
-
We attend other relevant patient focused policy discussions and are regularly invited to speak and attend international conferences and seminars;
-
We lobby on bladder cancer issues, and work to raise the profile of bladder cancer with decision makers and to influence the healthcare agenda.
Our work is only possible because of the enormous commitment and generosity of our many supporters those who donate, who fundraise or support our work in memory of a loved one. We would like to thank the many members of the public who raise much needed funds to support our work and help us to raise awareness. Many individuals show enormous commitment, and initiative, to supporting ABC UK and our much-needed work and we are extremely grateful to you all.
We would also like to thank the funders who have helped to support our work, as well as our corporate supporters (both those with a direct interest in bladder cancer and others).
Thank you to our wonderful team - the ABC UK staff team have continued to deliver much-needed support to patients with great commitment and professionalism and to develop and drive our new projects and programmes of work in 2025. We look forward to welcoming new members of the team in 2026.
- who work as part of our team and help to deliver all our projects and programmes and we would like to say a particular thank you to all the patients, and families and friends, who provide their commitment and personal experience to guide and inform everything we do We would also like to thank the clinicians and bladder cancer research experts who provide their expertise and continue to support and contribute to the work of ABC UK.
THANK YOU
Page 5
Action Bladder Cancer UK
Report of the Trustees
for the Year Ended 31 December 2025
FINANCIAL REVIEW
During the year ended 31st December 2025 the charity received income on an accruals basis totaling £175,074 (2024: £341,314 with regular oversight from Trustees at meetings.
Total expenditure for the period, including fundraising, operational and charitable expenditure, was £271,019 (2024: £267,861). Net expenditure on an accruals basis for the period was £95,945 (2024: Net income £73,453). At the end of the financial year unrestricted reserves were £378,671 (2024: £474,616). This allows for 18 months of core running costs with the remainder contributing to a planned research fund.
Whilst income reduced from 2024, this was mainly due to a delay in an expected funding commitment, which has now been confirmed for Q1 2026. ABC UK have been pleased to see income maintain a healthy level in 2026 with funding commitments looking very healthy.
We continue to have valued corporate partners. We have also been able to engage new funding supporters and are working to increase our funder base even further for 2026.
We are pleased to have been able to launch new projects and develop our existing, very successful, programmes of activity in 2025. This learning is feeding into our planned strategy review in 2026 for future development in 2026 and beyond. . We continue to be delighted with the successful development of our health professional education programme, the growth of our patient support service, events and support resources. The Trustees continue to be very pleased with our growing impact and successful programmes of work.
Reserves policy
It is the policy of the trustees to hold sufficient funds in hand to cover grant commitments and expenses for the current financial year and to maintain an appropriate budget for future years to ensure that they could cover longer term commitments. The Trustees were pleased that the income levels of 2025 ensured that the funds in hands were able to be maintained and increased.
The commitments and liabilities within one year totaled £36,407 as at 31 December 2025 (2024: £21,158). The Trustees considered that the cash balance of £412,949 as at 31 December 2025 was sufficient to cover these commitments and future financial commitments such as payroll and identified areas of increased expenditure for 2026 including building a research fund, new staff and project roles and delivering programmes of activity.
Going Concern
The Trustees of the charity believe that there are no material uncertainties that may cast significant doubt about the ability of the Charity to continue as a going concern.
Page 6
Action Bladder Cancer UK
Report of the Trustees for the Year Ended 31 December 2025
FUTURE DEVELOPMENTS
The charity has continued to expand our activity in 2025, building on our existing work and piloting new projects. The Board have been delighted with the growth in our impact and the development of the Charity.
Our excellent, and deeply committed, team continues to deliver our programmes as well as help us innovate and be responsive to patients and health professionals. We look forward to a specialist urology nurse joining our patient support team early in 2026. Our network of volunteers has grown considerably, and we will be continuing to build on this, and look forward to welcoming more patients and family members to the ABC UK team to helpto deliver our work, raise funds and awareness of bladder cancer.
Our network of bladder cancer patient volunteers has increased substantially these patients help deliver our programmes, run events, raise awareness and directly feed into all of our work. The ABC UK Patient Focus Group continues to be very active, providing input on new materials, programmes, research and helping us to develop new ideas.
The ABC UK Nurse Education Programme goes from strength to strength and is providing highly effective learning opportunities for specialist cancer and urology nurses. It also enables us to build a large community of specialist nurses, and strong networks in hospitals and Trusts across the UK. We are excited about the potential of this Programme for further development.
Our work to improve early diagnosis of bladder cancer has included the ABC UK online learning module for GPs. This is proving very successful, and we shall be widening our marketing of this, and other primary care resources, in 2026 to reach more GPs and community health networks.
We are proud that we are meeting a real unmet need for an education programme on bladder cancer for health professionals, and one which has considerable potential for the future.
Our work to support bladder cancer patients is the bedrock of everything we do. We have new, and updated, resources and have been running events and continue to expand our network of patient support groups across the UK.
We have expanded our awareness raising activity with new materials, both online and print. We attended many awareness events across the UK during 2025, and continued our programme of online workplace sessions. We are working to expand this activity by reaching more widely into the community.
Our Improving Outcomes for Patients grants Programme (IOPP) continues to grow in recognition and impact. The quality of applications are of high quality, and we are particularly pleased that some are in new, and exciting, areas of bladder cancer research. ABC UK feels that the impact of these grants is considerable, and is addressing a real need in the research community of providing grant funding for bladder cancer research, particularly for very valuable early stage research which can then enable wider research work. We are proud of the impact of our grant funding.
The Board and the ABC UK team look forward to 2026 to building on our successes, consolidate the future of the charity, and, to launch further new activity ].
ABC UK makes a big impact, and we are excited and committed to building on this in 2026.
Page 7
Action Bladder Cancer UK
for the Year Ended 31 December 2025
Report of the Trustees
STATEMENT OF TRUSTEES RESPONSIBILITIES
The Trustees are responsible for preparing the Report of the Trustees and the financial statements in accordance with applicable law and United Kingdom Generally Accepted Accounting Practice.
The law applicable to charities in England and Wales, the Charities Act 2011, Charity (Accounts and Reports) Regulations 2019 and the provisions of the trust deed requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the Charity and of the incoming resources and application of resources, including the income and expenditure, of the charity for that period. In preparing those financial statements, the Trustees are required to
-
select suitable accounting policies and then apply them consistently;
-
observe the methods and principles in the Charity SORP;
-
make judgements and estimates that are reasonable and prudent;
-
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in business.
The Trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the Charity and to enable them to ensure that the financial statements comply with the Charities Act 2011, the Charity (Accounts and Reports) Regulations 2019 and the provisions of the trust deed. They are also responsible for safeguarding the assets of the Charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The Trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charity's website.
ON BEHALF OF THE BOARD:
............................................. Roger Kockelbergh (Chair)
Date:
Page 8
Independent Examiner's Report to the Trustees of Action Bladder Cancer UK
Independent examiner's report to the trustees of Action Bladder Cancer UK
I report to the charity trustees on my examination of the accounts of the Charity for the year ended 31 December 2025.
Responsibilities and basis of report
As the charity's trustees you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 20 Act').
I report in respect of my examination of the accounts carried out under Section 145 of the Act and in carrying out my examination I have followed all applicable Directions given by the Charity Commission under Section 145(5) (b) of the Act.
Independent examiner's statement
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
-
accounting records were not kept in respect of the Charity as required by Section 130 the Act; or
-
the accounts do not accord with those records; or
-
the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Matthew Dobbins FCA
Dunkley's Woodlands Grange Woodlands Lane Bradley Stoke Bristol BS32 4JY Date: .............................................
Page 9
The notes form part of these financial statements
Action Bladder Cancer UK
Statement of Financial Activities for the Year Ended 31 December 2025
| Notes Income Donations 2 Fundraising events Interest received Total income EXPENDITURE Costs of generating funds 3 Costs of generating voluntary income Costs of generating sponsorship income Costs of fundraising events Charitable activities Educating the public/awareness raising 4 Patient support 4 Improving outcomes 4 Total expenditure NET EXPENDITURE Net movement in funds RECONCILIATION OF FUNDS Total funds brought forward TOTAL FUNDS CARRIED FORWARD |
Year Ended Year Ended 31.12.25 31.12.24 Unrestricted Total Total funds Funds Funds £ £ £ 125,229 125,229 286,239 47,306 2,539 47,306 2,539 52,612 2,463 |
|---|---|
| 175,074 175,074 341,314 4,131 4,131 3,152 11,922 11,922 9,096 3,653 3,653 10,265 |
|
| 19,706 19,706 22,513 77,124 77,124 65,070 136,911 136,911 130,019 37,278 37,278 50,259 |
|
| 251,313 251,313 245,348 |
|
| 271,019 271,019 267,861 |
|
| (95,945) (95,945) 73,453 |
|
| (95,945) (95,945) 73,453 |
|
| 474,616 474,616 401,163 378,671 378,671 474,616 |
Page 10
The notes form part of these financial statements
Action Bladder Cancer UK
Balance Sheet At 31 December 2025
| Notes CURRENT ASSETS Debtors 9 Cash at bank CREDITORS Amounts falling due within one year 10 NET CURRENT ASSETS CREDITORS Amounts filling due after more than one year 11 NET ASSETS FUNDS 12 Unrestricted funds TOTAL FUNDS |
Unrestricted funds £ 6,004 412,949 |
31.12.25 31.12.24 Total Total funds Funds £ £ 6,004 3,176 412,949 510,744 |
|---|---|---|
| 418,953 36,407 |
418,953 513,920 36,407 21,158 |
|
| 382,546 | 382,546 492,762 |
|
| 3,875 | 3,875 18,146 378,671 474,616 |
|
| 378,671 | ||
| 378,671 474,616 378,671 474,616 |
The financial statements were approved by the Board of Trustees on and were signed on its behalf by:
Roger Kockelbergh (Chair)
Jeremy Crew (Treasurer)
Page 11
The notes form part of these financial statements
Action Bladder Cancer UK
Notes to the Financial Statements for the Year Ended 31 December 2025
1. ACCOUNTING POLICIES
Accounting convention
These accounts have been prepared for the twelve-month period to 31[st] December 2025. The accounts have been prepared under the historical cost convention with items recognised at cost or transaction value unless otherwise stated in the relevant accounting policies below or the notes to these accounts. The accounts have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (Charities SORP FRS 102) 2019, the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Charities Act 2011. The charity constitutes a public benefit entity as defined by FRS 102. The accounts are presented in sterling and are rounded to the nearest pound.
Critical accounting estimates and areas of judgement
Preparation of the financial statements requires the trustees to make significant judgements and estimates. The trustees do not consider that there are any sources of estimation uncertainty or any key judgements made in the preparation of the financial statements.
Assessment of going concern
The trustees have assessed whether the use of the going concern assumption is appropriate in preparing these financial statements. The trustees have made this assessment in respect to a period of one year from the date of approval of these financial statements. The trustees of the charity have concluded that there are no material uncertainties related to events or conditions that may cast significant doubt on the ability of the charity to continue as a going concern. The trustees are of the opinion that the charity will have sufficient resources to meet its liabilities as they fall due.
Income
All income is included on the Statement of Financial Activities when the charity is legally entitled to the income, it is probable that it will be received and the amount can be quantified with reasonable accuracy.
Donated facilities - where the organisation is given facilities and services for its own use which it would otherwise have purchased, these are included in the organisation's accounts as income and expenditure when received, provided the value of the gift can be measured reliably.
Expenditure
Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources. Expenditure on grants is recorded once the charity has made an unconditional commitment to pay the grant and this is communicated to the beneficiary or the grant has been paid, whichever is earlier. Grants offered subject to conditions which have not been met at the period end date are noted as a commitment but not accrued as expenditure. Should circumstances arise where the grant is repayable, this is accounted for at the point when the grant is received. If this is after the balance sheet date and known about it is reflected in the accounts as a post balance sheet event.
Debtors
Debtors are recognised at their settlement amount, less any provision for non-recoverability. Prepayments are valued at the amount prepaid. They have been discounted to the present value of the future cash receipt where such discounting is material.
Cash at bank and in hand
Cash at bank and in hand represents such accounts and instruments that are available on demand or have a maturity of less than three months from the date of acquisition.
Page 12
Action Bladder Cancer UK
Notes to the Financial Statements
for the Year Ended 31 December 2025
Creditors and provisions
Creditors and provisions are recognised when there is an obligation at the balance sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably. Creditors and provisions are recognised at the amount the charity anticipates it will pay to settle the debt. They have been discounted to the present value of the future cash payment where such discounting is material.
Taxation and Value Added Tax
The charity is exempt from tax on its charitable activities.
Fund accounting
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.
Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.
Statement of cash flows
The financial statements do not include a statement of cash flows because the charity is exempt from the requirement to prepare such a statement under the Charities SORP FRS 102.
2. DONATIONS
| Donations Legacies Gift Aid Grants |
Year Ended Year Ended 31.12.25 31.12.24 £ £ 101,576 95,107 11,000 105,000 12,653 11,132 - 75,000 |
|---|---|
| 125,229 286,239 |
Page 13
Action Bladder Cancer UK Notes to the Financial Statements - continued for the Year Ended 31 December 2025
3. COSTS OF GENERATING FUNDS
| sts of generating voluntary income sts of generating sponsorship income sts of fundraising events CHARITABLE ACTIVITIES ucating the public/awareness raising tient support proving outcomes vernance costs (note 6) |
Year Ended Year Ended 31.12.25 31.12.24 £ £ 4,131 3,152 11,922 9,096 3,653 10,265 19,706 22,513 Year Ended Year Ended 31.12.25 31.12.24 £ £ 74,240 63,570 130,002 125,868 36,577 49,888 10,494 6,022 251,313 245,348 |
|---|---|
Page 14
Notes to the Financial Statements - continued for the Year Ended 31 December 2025
Action Bladder Cancer UK
5. GOVERNANCE COSTS
| Accountancy and book-keeping Incidental expenses Independent examination Secretariat Insurance 6. NET INCOME Net resources are stated after charging: Independent examination fees 7. STAFF COSTS AND EMOLUMENTS Salaries and fees Social Security costs Pension Homeworking costs |
Year Ended Year Ended 31.12.25 31.12.24 £ £ 2,872 1,658 284 314 1,746 1,116 5,153 2,538 439 396 |
|---|---|
| 10,494 6,022 | |
| Year Ended Year Ended 31.12.25 31.12.24 £ £ 1,746 1,116 |
|
| Year Ended Year Ended 31.12.25 31.12.24 £ £ 87,125 92,402 1,949 4,139 3,981 4,125 702 1,734 |
|
| 93,757 102,400 |
There were no employees whose emoluments as defined for taxation purposes amounted to over £60,000 in the period. The average number of employees analysed by function was:
| 2025 | 2024 | |
|---|---|---|
| Management and Administrative staff | 3.0 | 3.0 |
The average number of employees, calculated on a full-time equivalent basis was 2.3 (2024: 2.3). There was 1 full-time (2024: 1) and 2 part-time (2024: 2) members of staff employed during the year.
8
There were no trustees' remuneration or other benefits for the year ended 31 December 2025.
Trustees' Expenses
Trustees' travel expenses paid for the year ended 31 December 2025 totaled £401 (2024: £nil paid to no Trustees). Speaker fees amounting to £256 were paid to one Trustee in the year (2024: £500).
The trustees consider that they, and the Clerk to the trustees, comprise the key management of the charity in charge of directing and controlling, running and operating the charity on a day to day basis. The trustees receive no remuneration. During this period the Charity has employed a full time Head of Fundraising to support the income generation and development of the charity.
Page 15
Action Bladder Cancer UK
for the Year Ended 31 December 2025
Notes to the Financial Statements - continued
9. DEBTORS AND PREPAYMENTS
| **9. ** | DEBTORS AND PREPAYMENTS | ||
|---|---|---|---|
| Year Ended | Year Ended | ||
| 31.12.25 | 31.12.24 | ||
| £ | £ | ||
| Other Debtors | 4,673 | 1,163 | |
| Prepayments | 1,331 | 2,013 | |
| 6,004 | 3,176 | ||
| 10. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR | ||
| Year Ended | Year Ended | ||
| 31.12.25 | 31.12.24 | ||
| £ | £ | ||
| Other creditors | 7,605 | 7,497 | |
| Deferred income | 26,726 | 11,945 | |
| Accruals | 2,076 | 1,716 | |
| 36,407 | 21,158 | ||
| 11. | CREDITORS: AMOUNTS FALLING IN MORE THAN ONE YEAR | ||
| Year Ended | Year Ended | ||
| 31.12.25 | 31.12.24 | ||
| £ | £ | ||
| Deferred income | 3,875 | 18,146 |
| 12. | MOVEMENT IN FUNDS |
MOVEMENT IN FUNDS |
|||||
|---|---|---|---|---|---|---|---|
| At | 31.12.24 | Income | Expenditure | Net movement in funds |
At 31.12.25 | ||
| £ | £ | £ | £ | £ | |||
| Unrestricted funds | |||||||
| General fund | 474,616 | 175,074 | (271,019) | (95,945) | 378,671 | ||
| TOTAL FUNDS | 474,616 | 175,074 | (271,019) | (95,945) | 378,671 | ||
| ANALYSIS OF NET ASSETS BETWEEN | FUNDS |
| Unrestricted funds General fund TOTAL FUNDS |
Net Current Assets 31.12.25 Net Current Assets 31.12.24 £ £ 378,671 474,616 378,671 474,616 |
|---|---|
Page 16
Action Bladder Cancer UK
Notes to the Financial Statements - continued
for the Year Ended 31 December 2025
13. RELATED PARTY DISCLOSURES
Trustees' travel expenses paid for the year ended 31 December 2025 totaled £401 (2024: £nil paid to no Trustees). Speaker fees amounting to £256 were paid to one Trustee in the year (2024: £500).
There were no other related party transactions during the year. (2024: none).
14. CONTROL
The charity is controlled by its board of Trustees.
15 . POST BALANCE SHEET EVENTS
The trustees have considered any events occurring after the balance sheet date and confirm there are no material adjustments or disclosures to make to these financial statements.
16 . CONTINGENT LIABILITIES
The charity had no contingent liabilities at the balance sheet date or in the prior year.
- .
Page 17
Action Bladder Cancer UK Detailed Statement of Financial Activities for the Year Ended 31 December 2025
| Income Donations Gift Aid Legacies Activities for generating funds Sponsorship Fundraising events Interest received Total income EXPENDITURE Costs of generating funds Costs of generating voluntary income Costs of generating sponsorship income Costs of fundraising events Charitable activities Educating the public/awareness raising Patient support Improving outcomes Governance costs Accountancy and book-keeping Incidental expenses Independent examination Secretariat Insurance Total expenditure Net (expenditure)/income |
Year Ended Year Ended 31.12.25 31.12.24 £ £ 101,576 170,107 12,653 11,132 11,000 105,000 - - 47,306 2,539 52,612 2,463 |
|---|---|
| 175,074 341,314 4,131 3,152 11,922 9,096 3,653 10,265 |
|
| 19,706 22,513 74,240 63,570 130,002 125,868 36,577 49,888 |
|
| 240,819 239,326 2,872 1,658 284 314 1,746 1,116 5,153 2,538 439 396 |
|
| 10,494 6,022 271,019 267,861 |
|
| (95,945) 73,453 |
This page does not form part of the statutory financial statements
Page 18
ACTION BLADDER CANCER UK
Woodlands Grange Woodlands Lane Bradley Stoke Bristol BS32 4JY
September 2026
Dear Sirs & Madams
ACTION BLADDER CANCER UK INDEPENDENT EXAMINATION FOR THE YEAR ENDED 31 December 2025
This representation letter is provided in connection with your independent examination of the financial statements of the charity for the 31 December 2025 Charities Act 2011 requirements.
We confirm that the following representations are made on the basis of enquiries of the trustees, management and staff with relevant knowledge and experience (and, where appropriate, of inspection of supporting documentation) sufficient to satisfy ourselves that we can properly make each of the following representations to you:
REPRESENTATION
-
1 We have fulfilled our responsibilities as trustees under the Charities Act 2011 for preparing financial statements, in accordance with the applicable financial reporting framework [FRS 102 and the FRS 102 Charity SORP].
-
We confirm that in our opinion the financial statements give a true and fair view and in particular that where any additional information must be disclosed in order to give a true and fair view that information has in fact been disclosed. We confirm that the selection and application of the accounting policies used in the preparation of the financial statements are appropriate, and we approve these accounts for the period.
-
2 We confirm that all necessary accounting records have been made available to you for the purpose of your independent examination, in accordance with your terms of engagement, and that all the transactions undertaken by the charity have been properly reflected and recorded in the accounting records. All other relevant records and related information, available to you.
-
We have provided any additional information that you have requested for the purposes of your independent examination.
ACTION BLADDER CANCER UK CHARITY NUMBER 1164374
6 TRULL FARM BUILDINGS, TETBURY, GLOUCESTERSHIRE, GL8 8SQ
-
3 We confirm the charity has satisfactory title to all assets and there are no liens or encumbrances on the assets, except for those disclosed in the financial statements.
-
4 We confirm that significant assumptions used by us in making accounting estimates, including those measured at fair value, are reasonable.
None
-
5 We confirm that we have no plans or intentions that may materially alter the carrying value and, where relevant, the fair value measurements or classification of assets and liabilities reflected in the financial statements.
-
6 We confirm that the charity has no liabilities or contingent liabilities other than those disclosed in the financial statements.
-
7 We confirm that all known actual or possible litigation and claims whose effects should be considered when preparing the financial statements have been disclosed to you and accounted for and disclosed in accordance with the applicable financial reporting framework [FRS102 and the FRS102 Charity SORP].
-
8 We confirm that there have been no events since the balance sheet date which require disclosing or which would materially affect the amounts in the financial statements, other than those already disclosed or included in the financial statements.
None
- 9 We confirm that we are aware of the definition of a related party for the purpose of the accounting framework being applied in the preparation of the accounts.
We confirm that the related party relationships and transactions set out below are a complete list of such relationships and transactions and that we are not aware of any further related parties or transactions.
----- Start of picture text -----
Party Relationship Nature of transaction
ROGER KOCKELBERGH Chair None
Jenny Akins Trustee Expense claim for Speaker fee
Alexandra Colquhoun Trustee None
Caroline Raw Trustee None
DR Peter Harper FRCP Trustee None
Dr MARK PAGE Trustee None
Rik Bryan Trustee None
Allen Knight Trustee None
Paula Allchorne Trustee Expense claim for travel
JEREMY PAUL CREW Trustee None
Joanna Knight Spouse of Allen None
Ben Knight Son of Allen None
John Knight Brother of Allen None
James Akins Spouse of Jenny None
----- End of picture text -----
ACTION BLADDER CANCER UK CHARITY NUMBER 1164374
6 TRULL FARM BUILDINGS, TETBURY, GLOUCESTERSHIRE, GL8 8SQ
----- Start of picture text -----
Oliver Akins Child of Jenny None
Royal Life Saving Society Jenny is a member None
University of Birmingham Rik has current or previous None
employment
Cystotech ApS Denmark Rik is a consultant None
Nonacus Ltd UK Rik is a consultant None
Grande Prive Ltd Rik is founder and chairman None
The Urology Foundation Rik is co-founder None
National Bladder Cancer
Patient Group
Lisa Ryan Spouse of Rik None
Baron Davenports Charity Lisa Bryan is chairman None
American Society of Clinical Peter has None
Oncology membership/interest
Amsurg International Peter holds more that 5% None
share capital
Halcyon Days Holdings Peter holds more that 5% None
share capital
Karen Page Spouse of Mark Page None
Jonathan Raw Spouse of Caroline None
Pauline Tinker Mother of Caroline None
Kane Child of Caroline None
Oxford University Hospitals Jeremy Crew has None
Trust current/previous employment
Oxford University Urology Jeremy Crew is Director None
Specialist Ltd
Angela Wife of Jeremy None
Alexander Crew Child of Jeremy None
Amelia Crew Child of Jeremy None
----- End of picture text -----
-
10 We confirm that all related party relationships and transactions have been accounted for and disclosed in accordance with the applicable financial reporting framework [FRS102 and the FRS102 Charity SORP].
-
11 We confirm that the charity neither had, at any time during the year, any arrangement, transaction or agreement to provide credit facilities (including advances and credits granted by the charity) for trustees, nor provided guarantees of any kind on behalf of the trustees.
-
12 We confirm that the charity has not contracted for any capital expenditure other than as disclosed in the financial statements
ACTION BLADDER CANCER UK
CHARITY NUMBER 1164374
6 TRULL FARM BUILDINGS, TETBURY, GLOUCESTERSHIRE, GL8 8SQ
-
13 We confirm that the charity has complied with all aspects of contractual agreements that could have a material effect on the financial statements in the event of non-compliance.
-
14 We have disclosed to you all (if any) instances of non-compliance or suspected noncompliance with laws and regulations, whose effects should be considered when preparing the financial statements, together with the actual or contingent consequences which may arise therefrom.
Other than these matters, we are not aware of any actual or possible instances of noncompliance with laws or regulations whose effects should be considered when preparing financial statements of the charity.
- 15 We acknowledge our responsibility for the design, implementation and maintenance of internal controls to prevent and detect fraud. We confirm that we have disclosed to you the results of our risk assessment of the risk of fraud in the organisation.
We have disclosed to you all (if any) deficiencies in internal control of which we are aware.
-
16 We confirm that there have been no actual or suspected instances of fraud involving trustees, management or employees who have a significant role in internal control or that could have a material effect on the financial statements. We also confirm that we are not aware of any allegations of fraud by trustees, former trustees, analysts, employees, former employees, regulators or others.
-
17 the going concern basis on the grounds that current and future sources of funding or lusion, we
-
have taken into account all relevant matters of which we are aware, and have considered a period of at least one year from the date on which the financial statements are due to be approved.
-
18 We confirm that in our opinion the effects of uncorrected misstatements are immaterial, both individually and in aggregate, to the financial statements as a whole.
-
19 We confirm that all grants, donations and other income, including those subject to special terms or conditions or received for restricted purposes, have been notified to you. There have been no breaches of terms or conditions during the period regarding the application of such income.
-
20 We confirm that we are not aware of any matters of material significance that should be reported to regulators.
Yours faithfully
ACTION BLADDER CANCER UK CHARITY NUMBER 1164374
6 TRULL FARM BUILDINGS, TETBURY, GLOUCESTERSHIRE, GL8 8SQ
For and behalf of the board of trustees
ACTION BLADDER CANCER UK CHARITY NUMBER 1164374 6 TRULL FARM BUILDINGS, TETBURY, GLOUCESTERSHIRE, GL8 8SQ
ACT15B/DC/UMM September 2026
The Trustees Action Bladder Cancer UK 6 Trull Farm Buildings Tetbury Gloucestershire GL8 8SQ
Dear Sirs
ACTION BLADDER CANCER UK YEAR ENDED 31 DECEMBER 2025
In accordance with our normal practice we are writing to draw your attention to various matters which arose during the course of our independent examination of the charity's accounts for the year ended 31 December 2025.
1.
We have no comments to make concerning the qualitative aspects of the entity's accounting practices and financial reporting.
We did not encounter any significant difficulties during the independent examination, and there are no significant findings to draw to your attention.
2. Letter of representation
A draft of our proposed letter of representation is attached.
In all respects, the letter is routine.
3. Adjusted and unadjusted misstatements
There have been no unadjusted misstatements determined during the course of our independent examination (except for those considered to be clearly trivial).
4.
We propose an unmodified
.
5. Material weaknesses in the accounting and internal control systems
During the course of an independent examination, we do not test your systems and controls, however if we encounter any material deficiencies, we will report them to you.
We noted no material deficiencies to the systems and controls.
6. Other matters to be communicated
There are no other matters to communicate to you.
7. Other relevant matters
Directors: M Dobbins FCA M Dunkley FCA J Weston ACCA CTA L White FCCA Client Partners: F Davey
is the trading name of Dunkley & Co Ltd. VAT No. 927 518 209. Company Number: 2994930. Registered office: Woodlands Grange, Woodlands Lane, Bradley Stoke, Bristol, BS32 4JY. Registered in England. Registered to carry on audit work in the UK, regulated for a range of investment business activities, and licensed to carry out the reserved legal activity of non-contentious probate in England and Wales by the Institute of Chartered Accountants in England & Wales
We have complied with all relevant ethical requirements concerning independence.
We would like to take this opportunity of expressing our thanks to your staff for their assistance during the course of our independent examination.
Please note that this report has been prepared for the sole use of Action Bladder Cancer UK. It must not be disclosed to third parties, quoted or referred to, without our prior written consent. No responsibility is assumed by us to any other person.
If we can be of any further assistance, please contact Daniel Chapman.
Yours faithfully